{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:06:56Z","timestamp":1787242016143,"version":"build-2736575974"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Endocrine science remains underrepresented in European Union research programmes despite the fundamental role of hormone health in human well-being. Analysis of the CORDIS database reveals a persistent gap between the societal impact of endocrine disorders and their research prioritization. At national funding level, endocrine societies report limited or little attention of national research funding towards endocrinology. The EndoCompass project\u2014a joint initiative between the European Society of Endocrinology and the European Society of Paediatric Endocrinology, aimed to identify and promote strategic research priorities in endocrine science to address critical hormone-related health challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Research priorities were established through comprehensive analysis of the EU CORDIS database covering the Horizon 2020 framework period (2014-2020). Expert consultation in adrenal endocrinology was conducted to identify key research priorities, followed by broader stakeholder engagement including society members and patient advocacy groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>For adrenal disorders, research priorities span primary and secondary adrenal insufficiency, adrenal tumours, and endocrine hypertension. Key areas include development of biomarkers and replacement therapies, improved understanding of disease mechanisms, diagnostic procedure optimization, and establishment of pan-European registries. Special emphasis is placed on personalized treatment approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The adrenal component of the EndoCompass project provides an evidence-based roadmap for strategic research investment. This framework identifies crucial investigation areas into adrenal disease pathophysiology, prevention, and treatment strategies, ultimately aimed at reducing the burden of adrenal disorders on individuals and society. The findings support the broader EndoCompass objective of aligning research funding with areas of highest potential impact in endocrine health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf063","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:37:55Z","timestamp":1747035475000},"page":"ii12-ii22","source":"Crossref","is-referenced-by-count":2,"title":["EndoCompass project: research roadmap for adrenal and cardiovascular endocrinology"],"prefix":"10.1093","volume":"193","author":[{"given":"Eystein S","family":"Husebye","sequence":"first","affiliation":[{"name":"Department of Clinical Science, University of Bergen , N-5021 Bergen ,","place":["Norway"]},{"name":"Department of Medicine, Haukeland University Hospital , N-5021 Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Assi\u00e9","sequence":"additional","affiliation":[{"name":"Institut Cochin , INSERM U1016, CNRS UMR8104, F-75014 Paris ,","place":["France"]},{"name":"H\u00f4pital Cochin, Assistance Publique des H\u00f4pitaux de Paris\u2014Endocrinologie , F-75014 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3402-4727","authenticated-orcid":false,"given":"Nils","family":"Krone","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, University of Sheffield , Sheffield, South Yorkshire S10 2TN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Achermann","sequence":"additional","affiliation":[{"name":"UCL Great Ormond Street Institute of Child Health , Genetics and Genomic Medicine, London WC1N 1EH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-3249","authenticated-orcid":false,"given":"Barbara","family":"Altieri","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Internal Medicine I, Universit\u00e4tsklinikum \u00a0 W\u00fcrzburg, 97080 W\u00fcrzburg ,","place":["Germany"]},{"name":"Bavarian Cancer Research Center (BZKF), University Hospital of W\u00fcrzburg , 97080 W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-4276","authenticated-orcid":false,"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[{"name":"Hopital Europeen Georges Pompidou - Hypertension Unit , F-75015 Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris Cit\u00e9 , F-75006 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[{"name":"Hospital Universitario Ramon y Cajal, Endocrinology and Nutrition , 28034 Madrid ,","place":["Spain"]},{"name":"RYCIS, Investigaci\u00f3n Biom\u00e9dica I , 28034 Madrid, Comunidad de Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris J","family":"Brown","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Precision Medicine, The William Harvey Research Institute , Faculty of Medicine and Dentistry, University of London, London EC1M 6BQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth T","family":"Casey","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedi L","family":"Claahsen-van der Grinten","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Radboud University Medical Center , Amalia Children\u2019s Hospital, 6500 HB Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-5404","authenticated-orcid":false,"given":"Eleanor","family":"Davies","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , G12 8TA Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2465-1986","authenticated-orcid":false,"given":"Jaap","family":"Deinum","sequence":"additional","affiliation":[{"name":"Department of Medicine, Radboud University Medical Center , 6525 GA Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E","family":"Fl\u00fcck","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Bern, University Hospital Inselspital, University of Bern , Bern 3010 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Kastelan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital Centre Zagreb , 10000 Zagreb ,","place":["Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kroiss","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen, LMU University Hospital , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5480-1116","authenticated-orcid":false,"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Division of Internal Medicine and Hypertension, University of Torino , 10126 Torino ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5588-7855","authenticated-orcid":false,"given":"Saila","family":"Laakso","sequence":"additional","affiliation":[{"name":"University of Helsinki and Helsinki University Hospital\u2014Children\u2019s Hospital , 00290 Helsinki ,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon H","family":"Pearce","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University , Newcastle upon Tyne NE1 3BZ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":false,"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen, LMU University Hospital , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, Ludwig-Maximilians Universit\u00e4t M\u00fcnchen, LMU University Hospital , 80336 Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6256-5902","authenticated-orcid":false,"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[{"name":"Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO) , 28029 Madrid ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII) , 28029 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina L","family":"Ronchi","sequence":"additional","affiliation":[{"name":"Department of Metabolism and System Science, University of Birmingham , Birmingham B15 2TT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra A","family":"Vassiliadi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Evangelismos General Hospital, European Reference Network on Rare Endocrine Conditions (Endo-ERN) , 106 76 Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Wiegering","sequence":"additional","affiliation":[{"name":"Department of Pediatric, Hematology and Oncology, University Hospital of W\u00fcrzburg , 97080 Wuerzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Christina","family":"Zennaro","sequence":"additional","affiliation":[{"name":"Inserm, PARCC, Universit\u00e9 Paris Cit\u00e9 , F-75015 Paris ,","place":["France"]},{"name":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Europ\u00e9en Georges Pompidou , Service de G\u00e9n\u00e9tique, F-75015 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"10274","key":"2025101705015463700_lvaf063-B1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"2025101705015463700_lvaf063-B2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"issue":"12","key":"2025101705015463700_lvaf063-B3","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025101705015463700_lvaf063-B4","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"issue":"8809","key":"2025101705015463700_lvaf063-B5","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/0140-6736(92)91829-w","article-title":"21-Hydroxylase, a major autoantigen in idiopathic Addison's disease","volume":"339","author":"Winqvist","year":"1992","journal-title":"Lancet"},{"issue":"4","key":"2025101705015463700_lvaf063-B6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1530\/EJE-20-1268","article-title":"The natural history of 21-hydroxylase autoantibodies in autoimmune Addison's disease","volume":"184","author":"Wolff","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025101705015463700_lvaf063-B7","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.4049\/jimmunol.1400056","article-title":"High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients","volume":"193","author":"Dawoodji","year":"2014","journal-title":"J Immunol"},{"issue":"1","key":"2025101705015463700_lvaf063-B8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41467-021-21015-8","article-title":"GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility","volume":"12","author":"Eriksson","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"2025101705015463700_lvaf063-B9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/joim.13649","article-title":"A polygenic risk score to help discriminate primary adrenal insufficiency of different etiologies","volume":"294","author":"Aranda-Guill\u00e9n","year":"2023","journal-title":"J Intern Med"},{"issue":"1","key":"2025101705015463700_lvaf063-B10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1530\/EJE-09-0170","article-title":"Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study","volume":"161","author":"Johannsson","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025101705015463700_lvaf063-B11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1210\/jc.2014-3809","article-title":"A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia","volume":"100","author":"Mallappa","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025101705015463700_lvaf063-B12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1056\/NEJMoa2404656","article-title":"Phase 3 trial of crinecerfont in adult congenital adrenal hyperplasia","volume":"391","author":"Auchus","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"2025101705015463700_lvaf063-B13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2404655","article-title":"Phase 3 trial of crinecerfont in pediatric congenital adrenal hyperplasia","volume":"391","author":"Sarafoglou","year":"2024","journal-title":"N Engl J Med"},{"key":"2025101705015463700_lvaf063-B14","doi-asserted-by":"publisher","first-page":"718660","DOI":"10.3389\/fendo.2021.718660","article-title":"Sex-specific limitations in physical health in primary adrenal insufficiency","volume":"12","author":"Didriksen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2025101705015463700_lvaf063-B15","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1210\/jc.2018-02298","article-title":"Sex-specific risk of cardiovascular disease in autoimmune Addison disease-a population-based cohort study","volume":"104","author":"Skov","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"7053","key":"2025101705015463700_lvaf063-B16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","article-title":"Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study","volume":"313","author":"Walsh","year":"1996","journal-title":"BMJ"},{"issue":"5","key":"2025101705015463700_lvaf063-B17","doi-asserted-by":"publisher","first-page":"e015237","DOI":"10.1136\/bmjopen-2016-015237","article-title":"Systemic glucocorticoid use in Denmark: a population-based prevalence study","volume":"7","author":"Laugesen","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"2025101705015463700_lvaf063-B18","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025101705015463700_lvaf063-B19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"2025101705015463700_lvaf063-B20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"23","key":"2025101705015463700_lvaf063-B21","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"2025101705015463700_lvaf063-B22","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S2213-8587(23)00193-6","article-title":"Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study","volume":"11","author":"Terzolo","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2025101705015463700_lvaf063-B23","doi-asserted-by":"publisher","first-page":"101434","DOI":"10.1016\/j.beem.2020.101434","article-title":"Next-generation therapies for adrenocortical carcinoma","volume":"34","author":"Altieri","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"2025101705015463700_lvaf063-B24","doi-asserted-by":"publisher","first-page":"e000469","DOI":"10.1136\/jitc-2019-000469","article-title":"Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma","volume":"8","author":"Landwehr","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"4","key":"2025101705015463700_lvaf063-B25","doi-asserted-by":"publisher","first-page":"R135","DOI":"10.1530\/EJE-16-0189","article-title":"Management of endocrine disease: recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis","volume":"175","author":"Amar","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025101705015463700_lvaf063-B26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"key":"2025101705015463700_lvaf063-B27","doi-asserted-by":"publisher","first-page":"1279828","DOI":"10.3389\/fendo.2023.1279828","article-title":"Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas","volume":"14","author":"Araujo-Castro","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025101705015463700_lvaf063-B28","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41467-023-36769-6","article-title":"Genomic and immune landscape of metastatic pheochromocytoma and paraganglioma","volume":"14","author":"Calsina","year":"2023","journal-title":"Nat Commun"},{"issue":"7","key":"2025101705015463700_lvaf063-B29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2025101705015463700_lvaf063-B30","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2025101705015463700_lvaf063-B31","doi-asserted-by":"publisher","first-page":"898084","DOI":"10.3389\/fendo.2022.898084","article-title":"Adrenalectomy improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion: results of a RCT","volume":"13","author":"Morelli","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2025101705015463700_lvaf063-B32","doi-asserted-by":"publisher","first-page":"e13114","DOI":"10.1111\/jne.13114","article-title":"Clinical presentation and etiology of Cushing's syndrome: data from ERCUSYN","volume":"34","author":"Valassi","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"2025101705015463700_lvaf063-B33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1210\/endrev\/bnac034","article-title":"Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia","volume":"44","author":"Bertherat","year":"2023","journal-title":"Endocr Rev"},{"issue":"10258","key":"2025101705015463700_lvaf063-B34","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"14","key":"2025101705015463700_lvaf063-B35","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2025101705015463700_lvaf063-B36","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1093\/eurjpc\/zwaa108","article-title":"Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study","volume":"29","author":"Rossi","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"2025101705015463700_lvaf063-B37","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025101705015463700_lvaf063-B38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.121.18118","article-title":"Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study","volume":"79","author":"Hundemer","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"2025101705015463700_lvaf063-B39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"10","key":"2025101705015463700_lvaf063-B40","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41574-020-0382-4","article-title":"Pathogenesis and treatment of primary aldosteronism","volume":"16","author":"Zennaro","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"2025101705015463700_lvaf063-B41","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41581-023-00753-6","article-title":"Primary aldosteronism: molecular medicine meets public health","volume":"19","author":"Azizan","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"2025101705015463700_lvaf063-B42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.kint.2022.12.021","article-title":"New advances in endocrine hypertension: from genes to biomarkers","volume":"103","author":"Fernandes-Rosa","year":"2023","journal-title":"Kidney Int"},{"issue":"1","key":"2025101705015463700_lvaf063-B43","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1038\/s41467-022-32896-8","article-title":"Identification of risk loci for primary aldosteronism in genome-wide association studies","volume":"13","author":"Le Floch","year":"2022","journal-title":"Nat Commun"},{"issue":"14","key":"2025101705015463700_lvaf063-B44","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1161\/CIRCULATIONAHA.122.062349","article-title":"Genetic risk of primary aldosteronism and its contribution to hypertension: a cross-ancestry meta-analysis of genome-wide association studies","volume":"147","author":"Naito","year":"2023","journal-title":"Circulation"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/Supplement_2\/ii12\/64633678\/lvaf063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/Supplement_2\/ii12\/64633678\/lvaf063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:02:01Z","timestamp":1760691721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/Supplement_2\/ii12\/8281960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":44,"journal-issue":{"issue":"Supplement_2","published-print":{"date-parts":[[2025,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf063","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,10]]}}}